🇺🇸 FDA
Patent

US 11059879

Chimeric antigen receptor molecules and uses thereof

granted A61KA61K2039/507A61K2239/48

Quick answer

US patent 11059879 (Chimeric antigen receptor molecules and uses thereof) held by The Board of Regents of the University of Texas System expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/507, A61K2239/48, A61K38/00, A61K39/39558